Omkar Pharmachem Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	-	5.4	5.4	5.4	5.4
Other Revenue	4.65	-	-	-	-
Revenue	4.65	5.4	5.4	5.4	5.4
Revenue Growth (YoY)	-13.89%	-	-	-	100.00%
Cost of Revenue	2.09	1.61	1.61	1.39	1.75
Gross Profit	2.56	3.79	3.8	4.01	3.65
Selling, General & Admin	-	0.07	0.07	0.07	0.07
Other Operating Expenses	0.96	0.83	0.9	0.84	0.9
Operating Expenses	0.99	0.94	1.01	0.93	0.98
Operating Income	1.58	2.85	2.78	3.08	2.67
Interest Expense	-0.02	-0.17	-0.29	-0.47	-0.56
Interest & Investment Income	-	0.02	0.04	0.03	-
Other Non Operating Income (Expenses)	0.07	-	-	-	-
EBT Excluding Unusual Items	1.63	2.7	2.53	2.65	2.11
Pretax Income	1.63	2.7	2.53	2.65	2.11
Income Tax Expense	0.41	0.69	0.64	0.67	0.27
Net Income	1.22	2.01	1.89	1.98	1.83
Net Income to Common	1.22	2.01	1.89	1.98	1.83
Net Income Growth	-39.37%	6.24%	-4.40%	8.03%	-17.30%
Shares Outstanding (Basic)	-	10	10	10	10
Shares Outstanding (Diluted)	-	10	10	10	10
EPS (Basic)	-	0.20	0.19	0.20	0.18
EPS (Diluted)	-	0.20	0.19	0.20	0.18
EPS Growth	-	6.24%	-4.40%	8.97%	-18.02%
Free Cash Flow	2.28	2.4	2.86	2.76	1.96
Free Cash Flow Per Share	-	0.24	0.28	0.27	0.19
Gross Margin	55.14%	70.24%	70.28%	74.28%	67.57%
Operating Margin	33.87%	52.76%	51.56%	57.07%	49.41%
Profit Margin	26.19%	37.20%	35.02%	36.63%	33.91%
Free Cash Flow Margin	49.12%	44.35%	53.02%	51.09%	36.30%
EBITDA	1.61	2.9	2.83	3.11	2.69
EBITDA Margin	34.58%	53.63%	52.43%	57.57%	49.76%
D&A For EBITDA	0.03	0.05	0.05	0.03	0.02
EBIT	1.58	2.85	2.78	3.08	2.67
EBIT Margin	33.87%	52.76%	51.56%	57.07%	49.41%
Effective Tax Rate	25.18%	25.59%	25.20%	25.22%	13.02%
Revenue as Reported	4.72	5.42	5.44	5.43	5.4
Advertising Expenses	-	0.03	0.03	0.03	0.03